J
Jean Pierre Marolleau
Researcher at University of Picardie Jules Verne
Publications - 46
Citations - 2124
Jean Pierre Marolleau is an academic researcher from University of Picardie Jules Verne. The author has contributed to research in topics: Transplantation & Chemotherapy. The author has an hindex of 19, co-authored 46 publications receiving 1917 citations.
Papers
More filters
Journal ArticleDOI
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation
Philippe Menasché,Ottavio Alfieri,Stefan Janssens,William J. McKenna,Hermann Reichenspurner,Ludovic Trinquart,Jean-Thomas Vilquin,Jean Pierre Marolleau,Barbara Seymour,Jérôme Larghero,Stephen Lake,Gilles Chatellier,Scott D. Solomon,Michel Desnos,Albert Hagège +14 more
TL;DR: Myoblast injections combined with coronary surgery in patients with depressed LV function failed to improve echocardiographic heart function and the increased number of early postoperative arrhythmic events after myoblast transplantation warrants further investigation.
Journal ArticleDOI
Autologous Myoblast Transplantation for Oculopharyngeal Muscular Dystrophy: a Phase I/Iia Clinical Study
Sophie Périé,Capucine Trollet,Capucine Trollet,Capucine Trollet,Vincent Mouly,Vincent Mouly,Vincent Mouly,Valérie Vanneaux,Kamel Mamchaoui,Kamel Mamchaoui,Kamel Mamchaoui,Belaid Bouazza,Belaid Bouazza,Belaid Bouazza,Jean Pierre Marolleau,Pascal Laforêt,Françoise Chapon,Bruno Eymard,Gillian Butler-Browne,Gillian Butler-Browne,Gillian Butler-Browne,Jérôme Larghero,Jean Lacau St Guily +22 more
TL;DR: The hypothesis that a local injection of autologous myoblasts in the pharyngeal muscles is a safe and efficient procedure for OPMD patients is supported and a cell dose-dependant improvement in swallowing was even observed in this study.
Journal ArticleDOI
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.
Thierry Lamy,Gandhi Damaj,Pierre Soubeyran,Emmanuel Gyan,Guillaume Cartron,Krimo Bouabdallah,Remy Gressin,Jérôme Cornillon,Anne Banos,Katell Le Du,Mohamed Benchalal,Marie-Pierre Moles,Steven Le Gouill,J. Fleury,Pascal Godmer,Hervé Maisonneuve,Eric Deconinck,Roch Houot,Kamel Laribi,Jean Pierre Marolleau,Olivier Tournilhac,Bernard Branger,Anne Devillers,Jean Philippe Vuillez,Thierry Fest,Philippe Colombat,Valérie Costes,Vanessa Szablewski,Marie C. Béné,Vincent Delwail +29 more
TL;DR: R-CHOP alone is not inferior to R-CHop followed by RT in patients with nonbulky limited-stage DLBCL, and 5-year EFS was not statistically significantly different between the 2 arms, while overall survival was not different.
Journal ArticleDOI
Azacitidine in untreated acute myeloid leukemia: A report on 149 patients
Sylvain Thepot,Raphael Itzykson,Valerie Seegers,Christian Recher,Emmanuel Raffoux,Bruno Quesnel,Jacques Delaunay,Thomas Cluzeau,Anne Marfaing Koka,Aspasia Stamatoullas,M.P. Chaury,Caroline Dartigeas,Stéphane Cheze,Anne Banos,Pierre Morel,Isabelle Plantier,Anne-Laure Taksin,Jean Pierre Marolleau,Cécile Pautas,Xavier Thomas,Françoise Isnard,Blandine Beve,Yasmine Chait,Agnès Guerci,Norbert Vey,François Dreyfus,Lionel Ades,Norbert Ifrah,Hervé Dombret,Pierre Fenaux,Claude Gardin +30 more
TL;DR: Using MDS IWG 2006 response criteria, among patients with stable disease, those with hematological improvement had no significant survival benefit in a 7 months landmark analysis.
Journal ArticleDOI
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients
Luciane Zabijak,Christophe Attencourt,Caroline Guignant,Denis Chatelain,Paulo Marcelo,Jean Pierre Marolleau,Emmanuel Treiner +6 more
TL;DR: It is suggested that including MAIT-cell-specific markers or transcripts in the analysis of tumor-infiltrating lymphocytes could be a benefit to the diagnosis and follow-up of CRC patients.